A023910 Stock Overview
Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Daihan Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩27,950.00 |
| 52 Week High | ₩30,300.00 |
| 52 Week Low | ₩25,500.00 |
| Beta | 0.32 |
| 1 Month Change | -1.06% |
| 3 Month Change | 0.54% |
| 1 Year Change | -1.76% |
| 3 Year Change | -36.41% |
| 5 Year Change | -30.90% |
| Change since IPO | 645.33% |
Recent News & Updates
Recent updates
Here's Why Daihan PharmaceuticalLtd (KOSDAQ:023910) Can Manage Its Debt Responsibly
Mar 02
Daihan Pharmaceutical Co.,Ltd.'s (KOSDAQ:023910) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Feb 09
Can You Imagine How Daihan PharmaceuticalLtd's (KOSDAQ:023910) Shareholders Feel About The 34% Share Price Increase?
Jan 19What Kind Of Shareholders Hold The Majority In Daihan Pharmaceutical Co.,Ltd.'s (KOSDAQ:023910) Shares?
Dec 18Does Daihan PharmaceuticalLtd (KOSDAQ:023910) Have A Healthy Balance Sheet?
Nov 27Shareholder Returns
| A023910 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 0% | -3.0% | -3.0% |
| 1Y | -1.8% | -0.2% | 0.6% |
Return vs Industry: A023910 underperformed the KR Pharmaceuticals industry which returned -0.2% over the past year.
Return vs Market: A023910 underperformed the KR Market which returned 0.6% over the past year.
Price Volatility
| A023910 volatility | |
|---|---|
| A023910 Average Weekly Movement | 1.9% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A023910 has not had significant price volatility in the past 3 months.
Volatility Over Time: A023910's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | n/a | Sungyoung Lee | www.daihan.com |
Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions.
Daihan Pharmaceutical Co.,Ltd. Fundamentals Summary
| A023910 fundamental statistics | |
|---|---|
| Market cap | ₩164.35b |
| Earnings (TTM) | ₩28.43b |
| Revenue (TTM) | ₩195.91b |
5.8x
P/E Ratio0.8x
P/S RatioIs A023910 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A023910 income statement (TTM) | |
|---|---|
| Revenue | ₩195.91b |
| Cost of Revenue | ₩130.60b |
| Gross Profit | ₩65.31b |
| Other Expenses | ₩36.89b |
| Earnings | ₩28.43b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.83k |
| Gross Margin | 33.34% |
| Net Profit Margin | 14.51% |
| Debt/Equity Ratio | 0% |
How did A023910 perform over the long term?
See historical performance and comparison